^
    Back
    Association details:
    Biomarker:TP73 overexpression
    Cancer:Multiple Myeloma
    Drug:epirubicin (Topoisomerase II inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    New
    Source:
    EHA 2023
    Title:

    DNP73 PROMOTES DRUG RESISTANCE AND IMMUNE EVASION IN MULTIPLE MYELOMA BY MODULATING MYC/CD47 AXIS

    Published date:
    05/11/2023
    Excerpt:
    DNp73 overexpression promoted the proliferation of MM cells, and induced the resistance to epirubicin treatment.